If you're having trouble viewing this email, please click here Download the Brilliant Distinctions® Mobile App.
MEMBER #: $ConsumerId   |   POINT BALANCE: $TotalPoints   |   ACCOUNT LOG IN
	Dear $firstname,          Why not give yourself something special this Valentine’s Day – talk to your aesthetic provider to see if JUVÉDERM VOLUMA® XC or JUVÉDERM® XC is right for you.       As we age, our cheeks can lose volume and the skin may begin to sag. JUVÉDERM VOLUMA® XC is the first and only FDA-approved injectable gel specifically designed to correct age-related volume loss in the cheek area for adults over the age of 21. In fact, it gives you instant, natural-looking results that can last up to 2 years with optimal treatment.       TRY JUVÉDERM ® XC         To instantly smooth moderate to severe lines and wrinkles around the nose and mouth, there's JUVÉDERM® XC. It's the #1 selling dermal filler in the U.S.* Results can last up to 1 year with optimal treatment. *Data on File, Allergan, Inc., 2014 Schedule an appointment now!         What are possible side effects? For JUVÉDERM® XC, most side effects are mild or moderate in nature, and last 7 days or less. The most common side effects include temporary injection-site reactions such as: redness, pain/tenderness, firmness, swelling, lumps/bumps, bruising, itching, and discoloration. For JUVÉDERM VOLUMA® XC, side effects are moderate (uncomfortable), and generally last 2 to 4 weeks. The most common side effects include temporary reactions at the treatment site such as tenderness, swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. As with all skin-injection procedures, there is a risk of infection. To report a side effect with JUVÉDERM® XC or JUVÉDERM VOLUMA® XC, please call Allergan Product Surveillance at 1-800-624-4261. For more information, please see www.juvederm.com or call the Allergan Medical Information line at 1-800-433-8871. JUVÉDERM® XC and JUVÉDERM VOLUMA® XC injectable gels are available by prescription only. © 2015 Allergan, Inc. 2525 Dupont Drive, Irvine, CA 92612. ® and TM marks owned by Allergan, Inc. JUVÉDERM ® mark owned by Allergan Industrie SAS. Allergan reserves the right to alter or cancel the program with no advance notice or obligation. 1-800FLOWERS.COM ® is a registered trademark of 1-800FLOWERS.COM. KOHL'S is a registered trademark of Kohl's Illinois, Inc. Victoria's Secret is a registered trademark of Victoria's Secret Direct Brand Management, LLC.		APPROVED USES JUVÉDERM® XC injectable gel is for injection into areas of facial tissue where moderate to severe facial wrinkles and folds occur to temporarily add volume to the skin, especially around the nose and mouth. JUVÉDERM VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related volume loss in adults over the age of 21.   IMPORTANT SAFETY INFORMATION Are there any reasons why I should not receive JUVÉDERM® XC or JUVÉDERM VOLUMA® XC?   Do not use these products if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or if you are allergic to the proteins (gram-positive bacterial proteins) used to make the hyaluronic acid (HA) in these products. Do not use JUVÉDERM® XC or JUVÉDERM VOLUMA® XC if you are allergic to lidocaine.   What precautions should my healthcare professional advise me about?   • The safety of JUVÉDERM® XC and JUVÉDERM VOLUMA® XC injectable gels for use during pregnancy or in women who are breastfeeding has not been studied   • The safety of JUVÉDERM® XC for use in patients under 18 years and JUVÉDERM VOLUMA® XC for patients under 35 years or over 65 years has not been studied   • The safety and effectiveness of JUVÉDERM® XC for treatment of areas other than facial wrinkles and folds (such as lips) have not been established in clinical studies   • The safety and effectiveness of JUVÉDERM VOLUMA® XC for treatment in areas other than the cheek area have not been established in clinical studies   • The safety of JUVÉDERM® XC and JUVÉDERM VOLUMA® XC in patients with a history of excessive scarring (eg, hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied, and use may result in additional scars or changes in pigmentation   • The safety of JUVÉDERM VOLUMA® XC in patients with very thin skin in the cheek area and the safety of repeat treatments in patients has not been studied   • There is a possible risk of inflammation at the treatment site if laser procedures and chemical peeling are performed after treatment   • Patients who experience skin injury near the site of injection with these products may be at a higher risk for side effects   • Tell your healthcare professional if you are on therapy used to decrease the body’s immune response (immunosuppressive therapy). Use of these products may result in an increased risk of infection • Tell your healthcare professional if you are using medications that can prolong bleeding, such as aspirin, ibuprofen, or other blood thinners, as this may result in increased bruising or bleeding at the injection site • Minimize strenuous exercise and exposure to extensive sun or heat within the first 24 hours following treatment with JUVÉDERM VOLUMA® XC
You may unsubscribe or change your email preferences at any time if you no longer wish to receive our communications. If you would like to contact us, please mail all communications to: Allergan Inc., P.O. Box 19534 Irvine, CA 92623 USA Privacy Statement  |  Terms of Use  |  Allergan.com © 2015 Allergan, Inc. 2525 Dupont Drive, Irvine, CA 92612. ® and TM marks owned by Allergan, Inc. Allergan reserves the right to alter or cancel the program with no advance notice or obligation. APC15RU15